Exam (elaborations)

FULL TEST BANK LEHNE'S PHARMACOLOGY FOR NURSING CARE 11TH EDITION BY JACQUELINE ROSENJACK BURCHUM | LAURA D. ROSENTHAL| LATEST UPDATE 2024 PRINTED PDF| ORIGINAL DIRECTLY FROM THE PUBLISHER| 100% VERIFIED ANSWERS| DOWNLOAD IMMEDIETLY AFTER THE ORDER

3 purchases

Course
LEHNE\'S PHARMACOLOGY FOR NURSING CARE 11TH

Institution
LEHNE\'S PHARMACOLOGY FOR NURSING CARE 11TH

[Show more]

Preview 6 out of 859 pages

View example

Uploaded on September 16, 2024
Number of pages 859
Written in 2024/2025
Type Exam (elaborations)
Contains Questions & answers

Institution LEHNE'S PHARMACOLOGY FOR NURSING CARE 11TH
Course LEHNE'S PHARMACOLOGY FOR NURSING CARE 11TH

NurseJanetteRichardson Member since 7 months 80 documents sold

$16.00

Add to cart

Add to wishlist

100% satisfaction guarantee
Immediately available after payment
Both online and in PDF
No strings attached

FULL TEST BANK
LEHNE'S PHARMACOLOGY FOR NURSING CARE 11TH EDITION BY JACQUELINE
ROSENJACK BURCHUM | LAURA D. ROSENTHAL| LATEST UPDATE 2024
PRINTED PDF| ORIGINAL DIRECTLY FROM THE PUBLISHER| 100% VERIFIED ANSWERS| DOWNLOAD

IMMEDIETLY AFTER THE ORDER

, TABLE OF CONTENTS
UNIT I: INTRODUCTION ................................................................................................................................. 6
CHAPTER 1: ORIENTATION TO PHARMACOLOGY ................................................................................. 6
CHAPTER 2: APPLICATION OF PHARMACOLOGY IN NURSING PRACTICE ............................................. 9
CHAPTER 3: DRUG REGULATION, DEVELOPMENT, NAMES, AND INFORMATION .............................. 16
UNIT II: BASIC PRINCIPLES OF PHARMACOLOGY ........................................................................................ 20
CHAPTER 4: PHARMACOKINETICS....................................................................................................... 20
CHAPTER 5: PHARMACODYNAMICS ................................................................................................... 28
CHAPTER 6: DRUG INTERACTIONS ...................................................................................................... 32
CHAPTER 7: ADVERSE DRUG REACTIONS AND MEDICATION ERRORS ............................................... 40
CHAPTER 8: INDIVIDUAL VARIATION IN DRUG RESPONSES ............................................................... 47
CHAPTER 9: GENETIC AND GENOMIC CONSIDERATIONS ................................................................... 53
UNIT III: DRUG THERAPY ACROSS THE LIFE SPAN ....................................................................................... 63
CHAPTER 11: DRUG THERAPY DURING PREGNANCY AND BREAST-FEEDING ..................................... 63
CHAPTER 12: DRUG THERAPY IN PEDIATRIC PATIENTS ...................................................................... 68
CHAPTER 13: DRUG THERAPY IN OLDER ADULTS ............................................................................... 74
UNIT IV: PERIPHERAL NERVOUS SYSTEM DRUGS ....................................................................................... 81
SECTION 1: INTRODUCTION .................................................................................................................... 81
CHAPTER 14: BASIC PRINCIPLES OF NEUROPHARMACOLOGY ........................................................... 81
CHAPTER 15: PHYSIOLOGY OF THE PERIPHERAL NERVOUS SYSTEM .................................................. 86
SECTION 2: CHOLINERGIC DRUGS ........................................................................................................... 92
CHAPTER 16: MUSCARINIC AGONISTS AND ANTAGONISTS ............................................................... 92
CHAPTER 17: MUSCARINIC ANTAGONISTS ......................................................................................... 97
CHAPTER 18: CHOLINESTERASE INHIBITORS AND THEIR USE IN MYASTHENIA GRAVIS .................. 102
CHAPTER 19: DRUGS THAT BLOCK NICOTINIC CHOLINERGIC TRANSMISSION: NEUROMUSCULAR
BLOCKING AGENTS AND GANGLIONIC BLOCKING AGENTS .............................................................. 108
SECTION 3: ADRENERGIC DRUGS .......................................................................................................... 115
CHAPTER 20: ADRENERGIC AGONISTS .............................................................................................. 115
CHAPTER 21: ADRENERGIC ANTAGONISTS ....................................................................................... 123
CHAPTER 22: INDIRECT-ACTING ANTIADRENERGIC AGENTS ............................................................ 132
UNIT V: CENTRAL NERVOUS SYSTEM DRUGS ........................................................................................... 138
SECTION 4: INTRODUCTION .................................................................................................................. 138
CHAPTER 23: INTRODUCTION TO CENTRAL NERVOUS SYSTEM PHARMACOLOGY .......................... 138

, SECTION 5: DRUGS FOR NEURODEGENERATIVE DISORDERS ............................................................... 142
CHAPTER 24: DRUGS FOR PARKINSON’S DISEASE ............................................................................ 142
CHAPTER 25: ALZHEIMER’S DISEASE ................................................................................................. 150
CHAPTER 26: DRUGS FOR MULTIPLE SCLEROSIS .............................................................................. 156
SECTION 6: NEUROLOGIC DRUGS ......................................................................................................... 163
CHAPTER 27: DRUGS FOR SEIZURE DISORDERS ................................................................................ 163
CHAPTER 28: DRUGS FOR MUSCLE SPASM AND SPASTICITY............................................................ 174
SECTION 7: DRUGS FOR PAIN................................................................................................................ 179
CHAPTER 29: LOCAL ANESTHETICS ................................................................................................... 179
CHAPTER 30: GENERAL ANESTHETICS............................................................................................... 185
CHAPTER 31: OPIOID ANALGESICS, OPIOID ANTAGONISTS, AND NONOPIOID CENTRALLY ACTING
ANALGESICS ...................................................................................................................................... 193
CHAPTER 32: PAIN MANAGEMENT IN PATIENTS WITH CANCER ...................................................... 202
CHAPTER 33: DRUGS FOR HEADACHE............................................................................................... 212
SECTION 8: PSYCHOTHERAPEUTIC DRUGS............................................................................................ 218
CHAPTER 34: ANTIPSYCHOTIC AGENTS AND THEIR USE IN SCHIZOPHRENIA ................................... 218
CHAPTER 35: ANTIDEPRESSANTS ...................................................................................................... 227
CHAPTER 36: DRUGS FOR BIPOLAR DISORDER ................................................................................. 238
CHAPTER 37: SEDATIVE-HYPNOTIC DRUGS ...................................................................................... 244
CHAPTER 38: MANAGEMENT OF ANXIETY DISORDERS .................................................................... 259
CHAPTER 39: CENTRAL NERVOUS SYSTEM STIMULANTS AND ATTENTION-DEFICIT/HYPERACTIVITY
DISORDER .......................................................................................................................................... 264
SECTION 9: DRUG ABUSE ...................................................................................................................... 272
CHAPTER 40: SUBSTANCE USE DISORDERS I: BASIC CONSIDERATIONS ........................................... 272
CHAPTER 41: SUBSTANCE USE DISORDERS II: ALCOHOL .................................................................. 276
CHAPTER 42: SUBSTANCE USE DISORDERS III: NICOTINE AND SMOKING ........................................ 287
CHAPTER 43: SUBSTANCE USE DISORDERS IV: MAJOR DRUGS OF ABUSE OTHER THAN ALCOHOL
AND NICOTINE .................................................................................................................................. 293
UNIT VI: DRUGS THAT AFFECT FLUID AND ELECTROLYTE BALANCE ......................................................... 304
CHAPTER 44: DIURETICS.................................................................................................................... 304
CHAPTER 45: AGENTS AFFECTING THE VOLUME AND ION CONTENT OF BODY FLUIDS .................. 311
UNIT VII: DRUGS THAT AFFECT THE HEART, BLOOD VESSELS, AND BLOOD ............................................. 318
CHAPTER 46: REVIEW OF HEMODYNAMICS ..................................................................................... 318
CHAPTER 47: DRUGS ACTING ON THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM .................... 323

, CHAPTER 48: CALCIUM CHANNEL BLOCKERS ................................................................................... 330
CHAPTER 49: VASODILATORS ........................................................................................................... 335
CHAPTER 50: DRUGS FOR HYPERTENSION ....................................................................................... 341
CHAPTER 51: DRUGS FOR HEART FAILURE ....................................................................................... 352
CHAPTER 52: ANTIDYSRHYTHMIC DRUGS......................................................................................... 364
CHAPTER 53: PROPHYLAXIS OF CORONARY HEART DISEASE: DRUGS THAT HELP NORMALIZE
CHOLESTEROL AND TRIGLYCERIDE LEVELS ....................................................................................... 376
CHAPTER 54: DRUGS FOR ANGINA PECTORIS ................................................................................... 386
CHAPTER 55: ANTICOAGULANT, ANTIPLATELET, AND THROMBOLYTIC DRUGS .............................. 396
CHAPTER 56: MANAGEMENT OF ST-ELEVATION MYOCARDIAL INFARCTION .................................. 407
CHAPTER 57: DRUGS FOR HEMOPHILIA............................................................................................ 414
CHAPTER 58: DRUGS FOR DEFICIENCY ANEMIAS ............................................................................. 420
CHAPTER 59: HEMATOPOIETIC AGENTS ........................................................................................... 429
UNIT VIII: DRUGS FOR ENDOCRINE DISORDERS ....................................................................................... 435
CHAPTER 60: DRUGS FOR DIABETES MELLITUS ................................................................................ 435
CHAPTER 61: DRUGS FOR THYROID DISORDERS............................................................................... 444
CHAPTER 62: DRUGS RELATED TO HYPOTHALAMIC AND PITUITARY FUNCTION ............................. 453
CHAPTER 63: DRUGS FOR DISORDERS OF THE ADRENAL CORTEX ................................................... 459
UNIT IX: WOMEN’S HEALTH ...................................................................................................................... 466
CHAPTER 64: ESTROGENS AND PROGESTINS: BASIC PHARMACOLOGY AND NONCONTRACEPTIVE
APPLICATIONS ................................................................................................................................... 466
CHAPTER 65: BIRTH CONTROL .......................................................................................................... 472
CHAPTER 66: DRUG THERAPY OF INFERTILITY .................................................................................. 482
CHAPTER 67: DRUGS THAT AFFECT UTERINE FUNCTION ................................................................. 488
UNIT X: MEN’S HEALTH ............................................................................................................................. 495
CHAPTER 68: ANDROGENS................................................................................................................ 495
CHAPTER 69: DRUGS FOR ERECTILE DYSFUNCTION AND BENIGN PROSTATIC HYPERPLASIA .......... 502
UNIT XI: ANTIINFLAMMATORY, ANTIALLERGIC, AND IMMUNOLOGIC DRUGS ........................................ 508
CHAPTER 70: REVIEW OF THE IMMUNE SYSTEM ............................................................................. 508
CHAPTER 71: CHILDHOOD IMMUNIZATION ..................................................................................... 515
CHAPTER 72: IMMUNOSUPPRESSANTS ............................................................................................ 525
CHAPTER 73: ANTIHISTAMINES ........................................................................................................ 532
CHAPTER 74: CYCLOOXYGENASE INHIBITORS: NONSTEROIDAL ANTI-INFLAMMATORY DRUGS AND
ACETAMINOPHEN ............................................................................................................................. 541

, CHAPTER 75: GLUCOCORTICOIDS IN NONENDOCRINE DISORDERS ................................................. 550
UNIT XII: DRUGS FOR BONE AND JOINT DISORDERS ................................................................................ 559
CHAPTER 76: DRUG THERAPY OF RHEUMATOID ARTHRITIS ............................................................ 559
CHAPTER 77: DRUG THERAPY OF GOUT ........................................................................................... 564
CHAPTER 78: DRUGS AFFECTING CALCIUM LEVELS AND BONE MINERALIZATION .......................... 569
UNIT XIII: RESPIRATORY TRACT DRUGS .................................................................................................... 578
CHAPTER 79: DRUGS FOR ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE .............. 578
CHAPTER 80: DRUGS FOR ALLERGIC RHINITIS, COUGH, AND COLDS ............................................... 589
UNIT XIV: GASTROINTESTINAL DRUGS...................................................................................................... 596
CHAPTER 81: DRUGS FOR PEPTIC ULCER DISEASE ............................................................................ 596
CHAPTER 82: LAXATIVES ................................................................................................................... 604
CHAPTER 83: OTHER GASTROINTESTINAL DRUGS ............................................................................ 611
UNIT XV: NUTRITION AND COMPLEMENTARY THERAPY .......................................................................... 623
CHAPTER 84: VITAMINS .................................................................................................................... 623
CHAPTER 85: DRUGS FOR WEIGHT LOSS .......................................................................................... 633
CHAPTER 86: COMPLEMENTARY AND ALTERNATIVE THERAPY ....................................................... 641
UNIT XVI: DRUGS FOR INFECTIOUS DISEASES ........................................................................................... 646
CHAPTER 87: BASIC PRINCIPLES OF ANTIMICROBIAL THERAPY ....................................................... 646
CHAPTER 88: DRUGS THAT WEAKEN THE BACTERIAL CELL WALL I: PENICILLINS............................. 655
CHAPTER 89: DRUGS THAT WEAKEN THE BACTERIAL CELL WALL II: OTHER DRUGS ....................... 664
CHAPTER 90: BACTERIOSTATIC INHIBITORS OF PROTEIN SYNTHESIS: TETRACYCLINES, MACROLIDES,
AND OTHERS ..................................................................................................................................... 671
CHAPTER 91: AMINOGLYCOSIDES: BACTERICIDAL INHIBITORS OF PROTEIN SYNTHESIS ................. 683
CHAPTER 92: SULFONAMIDES AND TRIMETHOPRIM ....................................................................... 693
CHAPTER 93: DRUG THERAPY OF URINARY TRACT INFECTIONS ...................................................... 700
CHAPTER 94: ANTIMYCOBACTERIAL AGENTS ................................................................................... 709
CHAPTER 95: MISCELLANEOUS ANTIBACTERIAL DRUGS .................................................................. 721
CHAPTER 96: ANTIFUNGAL AGENTS ................................................................................................. 727
CHAPTER 97: ANTIVIRAL AGENTS I: DRUGS FOR NON-HIV VIRAL INFECTIONS ................................ 739
CHAPTER 98: ANTIVIRAL AGENTS II: DRUGS FOR HIV INFECTION AND RELATED OPPORTUNISTIC
INFECTIONS ....................................................................................................................................... 748
CHAPTER 99: DRUG THERAPY OF SEXUALLY TRANSMITTED DISEASES ............................................ 756
CHAPTER 100: ANTISEPTICS AND DISINFECTANTS ........................................................................... 763
UNIT XVII: DRUGS FOR PARASITIC DISEASES ............................................................................................ 769

, CHAPTER 101: ANTHELMINTICS ........................................................................................................ 769
CHAPTER 102: ANTIPROTOZOAL DRUGS I: ANTIMALARIAL AGENTS ................................................ 775
CHAPTER 103: ANTIPROTOZOAL DRUGS II: MISCELLANEOUS AGENTS ............................................ 782
CHAPTER 104: ECTOPARASITICIDES .................................................................................................. 787
UNIT XVIII: CANCER CHEMOTHERAPY....................................................................................................... 794
CHAPTER 105: BASIC PRINCIPLES OF CANCER THERAPY .................................................................. 794
CHAPTER 106: ANTICANCER DRUGS I: CYTOTOXIC AGENTS ............................................................. 803
CHAPTER 107: ANTICANCER DRUGS II: NONCYTOTOXIC AGENTS .................................................... 813
UNIT XIX: DRUGS FOR EYES, EARS, AND SKIN ........................................................................................... 820
CHAPTER 108: DRUGS FOR THE EYE CONDITIONS AND DISEASES.................................................... 820
CHAPTER 109: DRUGS FOR THE SKIN CONDITIONS .......................................................................... 828
CHAPTER 110: DRUGS FOR THE EAR CONDITIONS ........................................................................... 840
UNIT XX: TOXICOLOGY .............................................................................................................................. 847
CHAPTER 111: MANAGEMENT OF POISONING................................................................................. 847
CHAPTER 112: POTENTIAL WEAPONS OF BIOLOGIC, RADIOLOGIC, AND CHEMICAL TERRORISM ... 853

UNIT I: INTRODUCTION
CHAPTER 1: ORIENTATION TO PHARMACOLOGY

MULTIPLE CHOICE

1. THE NURSE IS TEACHING A PATIENT HOW A MEDICATION WORKS TO TREAT AN ILLNESS. TO DO
THIS, THE NURSE WILL RELY ON KNOWLEDGE OF:

A. CLINICAL PHARMACOLOGY.

B. DRUG EFFICACY.

C. PHARMACOKINETICS.

D. PHARMACOTHERAPEUTICS.

ANSWER>>D

PHARMACOTHERAPEUTICS IS THE STUDY OF THE USE OF DRUGS TO DIAGNOSE, TREAT, AND PREVENT
CONDITIONS. CLINICAL PHARMACOLOGY IS CONCERNED WITH ALL ASPECTS OF DRUG–HUMAN
INTERACTIONS. DRUG EFFICACY MEASURES THE EXTENT TO WHICH A GIVEN DRUG CAUSES AN
INTENDED EFFECT.

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller NurseJanetteRichardson. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for $16.00. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

68175 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 15 years now

Start selling

Exam (elaborations)

FULL TEST BANK LEHNE'S PHARMACOLOGY FOR NURSING CARE 11TH EDITION BY JACQUELINE ROSENJACK BURCHUM | LAURA D. ROSENTHAL| LATEST UPDATE 2024 PRINTED PDF| ORIGINAL DIRECTLY FROM THE PUBLISHER| 100% VERIFIED ANSWERS| DOWNLOAD IMMEDIETLY AFTER THE ORDER

Document information

Subjects

Connected book

More summaries for

Written for

Seller

Reviews received

Content preview